Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Open-Label, Multicenter Trial to Evaluate Ejection Fraction, End-Diastolic and End-Systolic Volumes, by Unenhanced and DEFINITY®-Enhanced 2D-Echo and Magnetic Resonance Imaging

NCT03719612 is registered in ClinicalTrials.gov with Lantheus Medical Imaging as lead sponsor.

NCT NCT03719612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03719612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Open-Label, Multicenter Trial to Evaluate Ejection Fraction, End-Diastolic and End-Systolic Volumes, by Unenhanced and DEFINITY®-Enhanced 2D-Echo and Magnetic Resonance Imaging
Lead sponsor
Lantheus Medical Imaging
Phase
Phase 3
Overall status
Completed
Start date
December 28, 2018
Completion date
January 9, 2020
Enrollment
160 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac disease